Table 4 Sensitivity, Specificity, NPV, PPV and odds ratio using 2 × 2 contingency tables.

From: Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients

Variables

SN %

SP %

NPV %

PPV %

Odds ratio (CI 95%)

MDA nmol/ml

80

62

14

98

6.73

SOD µg/ml

58

46

6

95

1.19

GSH µg/ml

48

54

5

95

1.09

CAT nmol.mol

55

52

6

96

1.36

IL1 pg/ml

82

79

19

99

17.43

IL2 pg/ml

68

64

10

97

3.79

IL4 pg/ml

77

75

14

98

9.51

IL6 pg/ml

72

72

12

98

6.67

IL8 pg/ml

60

60

7

97

2.29

IL13 pg/ml

62

58

8

97

2.33

IL17 pg/ml

61

66

8

97

3.10

HSP27 pg/ml

88

86

28

99

47.16

HSP70 pg/ml

76

72

14

98

8.48

HSP90 pg/ml

81

68

16

98

8.99

TNFa pg/ml

76

66

12

98

5.89

NO ppm

82

74

18

98

13.01

iNOS ppm

75

66

12

98

5.59

MMP1 ng/ml

58

45

5

95

1.12

MMP2 ng/ml

56

54

6

96

1.51

MMP3 ng/ml

57

60

7

96

1.99

MMP7 ng/ml

58

62

7

97

2.32

MMP8 ng/ml

72

54

9

97

3.15

MMP9 ng/ml

87

81

25

99

27.54

Vitamin A IU

60

58

7

96

2.10

Vitamin C mg/dL

75

44

8

96

2.26

Vitamin D nmol/L

64

48

7

96

1.65